Federated Hermes
LPCN icon

Federated Hermes’s Lipocine LPCN Stock Holding History

Federated Hermes’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4
Closed -$1K – 2315
2020
Q1 		$1K Sell
4
-1
-20% -$8 ﹤0.01% 2120
2019
Q4 		$1K Sell
5
-3
-38% -$77 ﹤0.01% 2113
2019
Q3 		$1K Sell
8
-10
-56% -$401 ﹤0.01% 2113
2019
Q2 		$1K Sell
18
-19
-51% -$586 ﹤0.01% 2114
2019
Q1 		$1K Sell
37
-44
-54% -$1.35K ﹤0.01% 2105
2018
Q4 		$2K Sell
81
-107
-57% -$2.48K ﹤0.01% 2084
2018
Q3 		$4K Sell
188
-124
-40% -$3.05K ﹤0.01% 2085
2018
Q2 		$7K Sell
312
-289
-48% -$6.89K ﹤0.01% 1962
2018
Q1 		$16K Sell
601
-4,367
-88% -$122K ﹤0.01% 1801
2017
Q4 		$291K Sell
4,968
-70
-1% -$4.35K ﹤0.01% 1463
2017
Q3 		$340K Sell
5,038
-143
-3% -$10.3K ﹤0.01% 1426
2017
Q2 		$354K Buy
5,181
+437
+9% +$28.5K ﹤0.01% 1450
2017
Q1 		$315K Sell
4,744
-59
-1% -$3.83K ﹤0.01% 1428
2016
Q4 		$301K Buy
4,803
+6
+0.1% +$380 ﹤0.01% 1429
2016
Q3 		$364K Buy
+4,797
New +$297K ﹤0.01% 1367

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Federated Hermes's LPCN Position: Q2 2020 in Review

Federated Hermes sold out of Lipocine (LPCN) in Q2 2020, closing a stake of 4 shares — an estimated $1K sold.

Federated Hermes first reported a position in LPCN in Q3 2016 and held it in 15 quarters. The position peaked at $364K in Q3 2016. 33 funds tracked by Wall St. Rank hold LPCN as of Q2 2020.

  • Federated Hermes reported no remaining Lipocine position as of Q2 2020 after selling out during the quarter.
  • Federated Hermes sold 4 Lipocine shares in Q2 2020, an estimated $1K.
  • Federated Hermes first reported a position in Lipocine in Q3 2016 and held it in 15 quarters.
  • Federated Hermes's Lipocine position peaked at $364K in Q3 2016.
  • 33 funds tracked by Wall St. Rank held Lipocine as of Q2 2020.

Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.